- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $356.97M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $370.99M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $362.37M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $378.19M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.13B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.25B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.35B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.46B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $923.02M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $970.36M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 517.99M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $33.68M |
| Capex | Q1 2025 · Mar 31, 2024 | $1.19M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $426K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.21B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.24B |
| Net Income | Q1 2025 · Mar 31, 2024 | −$36.06M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$49.85M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $84.16M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $33.81M |
| Revenue | Q1 2025 · Mar 31, 2024 | $117.97M |